Abstract
Importance Case and death counts, government rules limiting social contact, media attention, peer behaviors, and analogies to war have all influenced public perceptions of risk to COVID-19. During an epidemic, the general public may not be accurately interpreting their individual risks from COVID19. U.S. public sentiment surveys indicate a high level of apprehension about routine community activities. Sufficient data allow estimating individual-level probabilities of infection, hospitalization, and death from community level contacts.
Objective Our objective is to estimate the average probability of acquiring COVID19 infection, being hospitalized or dying from a single unprotected and substantive community level contact with an individual of unknown infection status.
Design We estimate individual level probability of a contact resulting in infection using established principles of infection transmission, published data on the secondary attack rate, the current case incidence, the infectious period, the proportion of asymptomatic infection, and the case hospitalization and infection fatality ratios.
Setting U.S. Counties
Outcomes Probabilities of COVID19 infection, hospitalization, and death from a single unprotected person-contact in a community setting.
Results Among the 100 most populous US Counties, the median probability of COVID19 infection transmission at the end of May 2020 is 1 infection per 3836 unprotected community-level contacts (Range: 626 to 31,800). For a 50 to 64 year old individual, the estimated median probability of hospitalization is 1 hospitalization per 852,000 community level person contacts (Range: 139,000 to 7,080,000). For a 50 to 64 year old individual, the median probability of a fatality is 1 fatality per 19.1million community-level person-contacts (Range,:3.13 million to 159,000,000 million).
Conclusions and Relevance Across the country, current probabilities of infection transmission, hospitalization, and death from COVID19 vary substantially, yet severe outcomes are still rare events. Individuals may be overestimating their risks of hospitalization and death and a moderate number and frequency of community contacts is unlikely to overwhelm hospital capacity in most U.S. settings. Systematic public reporting of COVID19 case incidence and prevalence of seropositivity by age, risk group, locality and setting would improve individual-level risk estimation.
Question What is the average probability of acquiring COVID-19 infection, being hospitalized, or dying from an unprotected community-level contact in US?
Findings Among the 100 most populous US Counties, for the week ending May 30, 2020, the median probability of COVID-19 infection transmission is 1 infection per 3836 unprotected community-level contacts. For a 50 to 64 year old individual, the estimated median probability of hospitalization is 1 hospitalization per 852,000 community level person-contacts and the median probability of a fatality is 1 fatality per 19.1 million community-level person-contacts.
Meaning Estimates of individual level probability for COVID-19 infection may inform more accurate risk perceptions and facilitate re-engagement with social activity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding support
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
NA
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
drajiv{at}stanford.edu
JDKlausner{at}mednet.ucla.edu
Data Availability
All data used in the manuscript is publicly available and sources are referenced.